title: [Treatment of recurrent condyloma acuminatum with solid lipid nanoparticle gel containing podophyllotoxin: a randomized double-blinded, controlled clinical trial].
abstract: OBJECTIVE
  To observe the clinical efficacy and safety of podophyllotoxin delivered via solid lipid nanoparticle gel for topic treatment of recurrent condyloma acuminatum.
  
  
  METHODS
  In a randomized double-blinded study, podophyllotoxin solid lipid nanoparticles gel and routine podophyllotoxin gel preparation was applied respectively for treatment of 97 volunteer patients with recurrent condyloma acuminatum. The therapeutic effect, condyloma acuminatum relapse following the treatment and adverse effect were evaluated.
  
  
  RESULTS
  The wart clearance rate in the condyloma acuminatum patients in the first treatment course with podophyllotoxin solid lipid nanoparticle gel reached 97.1%, close to that with the routine preparation of 90.6%, but the nanoparticle preparation significantly reduced the recurrence rate and adverse effect (P<0.01).
  
  
  CONCLUSIONS
  Podophyllotoxin delivered via solid lipid nanoparticle gel can effectively clear condyloma acuminatum and reduce its recurrence rate with only mild, tolerable adverse effect.
authors.affiliation: Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Pfk303@163.com
authors.forename: Fang-ming
authors.initials: FM
authors.lastname: Xie
authors.forename: Kang
authors.initials: K
authors.lastname: Zeng
authors.forename: Zhi-liang
authors.initials: ZL
authors.lastname: Chen
authors.forename: Guo-feng
authors.initials: GF
authors.lastname: Li
authors.forename: Zhong-fang
authors.initials: ZF
authors.lastname: Lin
authors.forename: Xiao-liang
authors.initials: XL
authors.lastname: Zhu
authors.forename: Le-dong
authors.initials: LD
authors.lastname: Sun
mesh_terms: D000293:Adolescent; D000328:Adult; D003218:Condylomata Acuminata / Q000188:drug therapy* / Q000473:pathology; D004311:Double-Blind Method; D016503:Drug Delivery Systems; D005260:Female; D005782:Gels; D006801:Humans; D008055:Lipids / Q000737:chemistry*; D008297:Male; D008875:Middle Aged; D053758:Nanoparticles / Q000737:chemistry*; D011034:Podophyllotoxin / Q000008:administration & dosage* / Q000737:chemistry; D055502:Secondary Prevention; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D005782:Gels; D008055:Lipids; D011034:Podophyllotoxin